24 May 2013
Keywords: teva, files, anda, gilead, atripla, firm, sciences
Article | 07 April 2009
US firm Gilead Sciences says it has received a Paragraph IV Certification notification advising that Israel-based Teva
Pharmaceuticals had submitted ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 April 2009
6 April 2009
23 May 2013
© 2013 thepharmaletter.com